Publications in collaboration with researchers from Pharmacoeconomics and Outcomes Research Iberia (2)

2012

  1. Budgetary impact analysis of buprenorphine-naloxone combination (suboxone®) in Spain

    Health Economics Review, Vol. 2, Núm. 1, pp. 1-9

2010

  1. Suboxone® (buprenorphine/naloxone) as an agonist opioid treatment in Spain: A budgetary impact analysis

    European Addiction Research, Vol. 16, Núm. 1, pp. 31-42